cd279 (pd1) antibody, anti-human, reafinity (Miltenyi Biotec)
Miltenyi Biotec is a verified supplier 
Miltenyi Biotec manufactures this product 
93
Structured Review
Miltenyi Biotec
cd279 (pd1) antibody, anti-human, reafinity
Cd279 (Pd1) Antibody, Anti Human, Reafinity, supplied by Miltenyi Biotec, used in various techniques. Bioz Stars score: 93/100, based on 68 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/pd1/CD279+(PD1)+Antibody%2C+anti-human%2C+REAfinity/custom%40130-135-337%4042502392
Average 93 stars, based on 68 article reviews
Cd279 (Pd1) Antibody, Anti Human, Reafinity, supplied by Miltenyi Biotec, used in various techniques. Bioz Stars score: 93/100, based on 68 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/pd1/CD279+(PD1)+Antibody%2C+anti-human%2C+REAfinity/custom%40130-135-337%4042502392
Average 93 stars, based on 68 article reviews
cd279 (pd1) antibody, anti-human, reafinity - by Bioz Stars,
2026-09
93/100 stars
Images
Related Articles
Expressing:Article Title: Straightforward Generation of Ultrapure Off-the-Shelf Allogeneic CAR-T Cells Article Snippet: .. The proportion of T-cells expressing the CAR or different markers at their surface was then quantified using the following antibodies: anti-CD3 CAR [according to ( )]: Biotin-labeled polyclonal goat anti-mouse F(Ab’) 2 (Jackson Immunoresearch #115-065-07), streptavidin-APC (BD Bioscience #554067), CD3: Clone BW264/56, Vioblue (Miltenyi #130-094-363), TCRαβ: Clone REA652, PE (Miltenyi #130-109-920), CD4: Clone VIT4, PEVio770 (Miltenyi #130-096-552), CD8: Clone SK1, BV510 (Biolegend #344732), CD62L: Clone 145/15, APC (Miltenyi #130-113-617), CD45RA: Clone T6D11, Vioblue (Miltenyi #130-113-360), Marker:Article Title: A Microfluidics Approach for Ovarian Cancer Immune Monitoring in an Outpatient Setting. Article Snippet: .. Cells were washed before adding the following cell surface marker stains: CD45 (PE-Cy5, clone HI30, REF 15-0459-42, eBioscence, Merelbeke, Belgium), CD8 (PE-Cy7, clone HiT8, REF 300914, Biolegend, Amsterdam, The Netherlands), Article Title: A Microfluidics Approach for Ovarian Cancer Immune Monitoring in an Outpatient Setting Article Snippet: .. Cells were washed before adding the following cell surface marker stains: CD45 (PE-Cy5, clone HI30, REF 15-0459-42, eBioscence, Merelbeke, Belgium), CD8 (PE-Cy7, clone HTT8, REF 300914, Biolegend, Amsterdam, The Netherlands), other:Article Title: Repurposing endogenous immune pathways to tailor and control chimeric antigen receptor T cell functionality Article Snippet: |